ALK inhibitor shows high response rate in patients with advanced NSCLC harboring a specific gene alteration
11 Jun 2010
ALK inhibitor shows high response rate in patients with advanced NSCLC harboring a specific gene alteration
New agent, eribulin, derived from marine sponge, increases survival among women with metastatic breast cancer
Antibody drug ipilimumab improves long-term survival in previously treated advanced melanoma
Breast cancer during pregnancy
Metastatic colorectal cancer management
American Society of Hematology Meeting, 5-9th Dec 2009
NCRI Presentation: Elements of epithelial cancer
European Association for Cancer Research
ECCO 15 - ESMO 34 Conference
Guidelines for safer handling of cytotoxics
DNA damage, oncogene activation and chromatin
ECCO 15 - ESMO 34 News 22nd September 2009